Lujun X. Shen

651 Dongfeng East Rd
Guangzhou, 510060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 86 publications

Hepatic arterial infusion or intravenous infusion of adebrelimab, combined with bevacizumab and HAIC of the FOLFOX regimen for advanced unresectable hepatocellular carcinoma (HAIBrave-001 trial): a study protocol of a prospective, double-arm, phase II trial.

Hepatic arterial infusion or intravenous infusion of adebrelimab, combined with bevacizumab and HAIC of the FOLFOX regimen for advanced unresectable hepatocellular carcinoma (HAIBrave-001 trial): a study protocol of a prospective, double-arm, phase II trial.

Journal: Journal of gastrointestinal oncology

Published: June 02, 2026

Noninvasive Profiling for PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma.

Noninvasive Profiling for PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma.

Journal: Radiology

Published: January 13, 2026

Transarterial chemoembolisation-based combination therapy as a potential new standard for intermediate-stage hepatocellular carcinoma in the targeted immunotherapy era.

Transarterial chemoembolisation-based combination therapy as a potential new standard for intermediate-stage hepatocellular carcinoma in the targeted immunotherapy era.

Journal: BMJ open gastroenterology

Published: October 29, 2025

Consensus from the Asian conference on tumor ablation working group on image-guided thermal ablation for lung tumor: 10 key questions and answers.

Consensus from the Asian conference on tumor ablation working group on image-guided thermal ablation for lung tumor: 10 key questions and answers.

Journal: Journal of cancer research and therapeutics

Published: August 11, 2025

Thermal ablation versus hepatectomy in patients with liver metastases from RAS-mutated colorectal cancer.

Thermal ablation versus hepatectomy in patients with liver metastases from RAS-mutated colorectal cancer.

Journal: Journal of cancer research and therapeutics

Published: July 19, 2025

Comparison of the Effectiveness of Transarterial Bland Embolization and Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Propensity Score Matched Study of 980 Patients.

Comparison of the Effectiveness of Transarterial Bland Embolization and Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: A Propensity Score Matched Study of 980 Patients.

Journal: Journal of vascular and interventional radiology : JVIR

Published: June 20, 2025

Efficacy and safety of adebrelimab plus bevacizumab in combination with hepatic artery infusion chemotherapy for advanced stage hepatocellular carcinoma: a retrospective cohort study.

Efficacy and safety of adebrelimab plus bevacizumab in combination with hepatic artery infusion chemotherapy for advanced stage hepatocellular carcinoma: a retrospective cohort study.

Journal: Neoplasma

Published: May 08, 2025

Development and validation of the NTAA prognostic model for BCLC stage B hepatocellular carcinoma undergoing transarterial chemoembolization: a retrospective multicenter cohort study.

Development and validation of the NTAA prognostic model for BCLC stage B hepatocellular carcinoma undergoing transarterial chemoembolization: a retrospective multicenter cohort study.

Journal: International journal of surgery (London, England)

Published: April 23, 2025

PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacy.

PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacy.

Journal: Frontiers in immunology

Published: March 28, 2025

Letter to the Editor: The divergences in the efficacy of adjuvant transarterial chemoembolization for HCC- In-depth analysis and enlightenments.

Letter to the Editor: The divergences in the efficacy of adjuvant transarterial chemoembolization for HCC- In-depth analysis and enlightenments.

Journal: Hepatology (Baltimore, Md.)

Published: January 24, 2025

The Impact of Microwave Ablation on Recurrence and Metastasis of Hepatocellular Carcinoma: Insights From Animal Studies and Cytokine Profiling.

The Impact of Microwave Ablation on Recurrence and Metastasis of Hepatocellular Carcinoma: Insights From Animal Studies and Cytokine Profiling.

Journal: Journal of hepatocellular carcinoma

Published: January 05, 2025

Long-Term Analysis of Recurrence Beyond Milan Criteria Following Ablation of Solitary Early-Stage Hepatocellular Carcinoma ≤3 cm in Potentially Transplantable Patients: A Over 10-Year Survival Study.

Long-Term Analysis of Recurrence Beyond Milan Criteria Following Ablation of Solitary Early-Stage Hepatocellular Carcinoma ≤3 cm in Potentially Transplantable Patients: A Over 10-Year Survival Study.

Journal: Journal of hepatocellular carcinoma

Published: November 12, 2024

Showing 1-12 of 86

Last Updated: 09/26/2026